Taylor Daphne has filed 16 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 11500 shares of Aptevo Therapeutics Inc. ($APVO) on August 06, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2025 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | A | Restricted Stock Unit | 11500 | $0.00 | 11,500.0000 | 1,458,445 | 9999.99% | 0.79% |
| July 17, 2025 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Common Stock | 3 | $0.00 | 3.0000 | 1,458,445 | 9999.99% | 0.00% |
| July 17, 2025 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Restricted Stock Unit | 3 | $0.00 | 8.0000 | 1,458,445 | 27.27% | 0.00% |
| March 2, 2025 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Common Stock | 2 | $0.00 | 17.0000 | 1,458,445 | 13.33% | 0.00% |
| March 4, 2025 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Common Stock | 1 | $0.00 | 18.0000 | 1,458,445 | 5.88% | 0.00% |
| March 2, 2025 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Restricted Stock Unit | 2 | $0.00 | 2.0000 | 1,458,445 | 50.00% | 0.00% |
| March 4, 2025 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Restricted Stock Unit | 1 | $0.00 | 0.0000 | 1,458,445 | 100.00% | 0.00% |
| Aug. 8, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Common Stock | 158 | $0.00 | 576.0000 | 0 | 37.80% | 0.00% |
| Aug. 8, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Restricted Stock Unit | 158 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 17, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | A | Restricted Stock Unit | 8550 | $0.00 | 8,550.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Common Stock | 3667 | $0.00 | 16,827.0000 | 0 | 27.86% | 0.00% |
| March 4, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Common Stock | 1584 | $0.00 | 18,411.0000 | 0 | 9.41% | 0.00% |
| March 2, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Restricted Stock Unit | 3667 | $0.00 | 7,333.0000 | 0 | 33.34% | 0.00% |
| March 4, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Restricted Stock Unit | 1584 | $0.00 | 1,583.0000 | 0 | 50.02% | 0.00% |
| Jan. 29, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Common Stock | 792 | $0.00 | 13,160.0000 | 0 | 6.40% | 0.00% |
| Jan. 29, 2024 | Aptevo Therapeutics Inc. | $APVO | Taylor Daphne | SVP, CFO | M | Restricted Stock Unit | 792 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |